2022 J.P. Morgan x IQVIA Healthcare Virtual Summit: Navigating Global Market Dynamics and Cross-Border Innovation Strategies

In 2021, the global pharmaceutical industry is undergoing subtle yet significant changes, with “professionalism, depth, openness, and collaboration” emerging as new development trends. Driven by the recurring pandemic and robust demand from various stakeholders, EBP has assumed an increasingly pivotal role within the global pharmaceutical innovation ecosystem, positioning itself as one of the most watched and promising key players in the global capital markets.

China is the world’s second-largest healthcare market, with favorable policies, talent, and capital all converging to support this fertile ground for innovation.How Can We Balance Drug Accessibility with Sustaining Industry Innovation?As thousands of sails pass by, the aspiration to reach the clouds remains unshaken—a critical challenge not only for Chinese pharmaceutical companies but also for the global industry.

The 2022 J.P. Morgan x IQVIA Healthcare Cloud Summit will hold a domestic session and an overseas session on January 6 (Thursday) and January 7 (Friday), respectively., inviting you to jointly decode the market landscape at home and abroad, explore strategies for Chinese enterprises to go global and penetrate overseas markets—particularly how to build momentum and leverage opportunities in the U.S. market—while also providing strategic advice to overseas enterprises, working together toward a path of integration, breakthrough, and win-win cooperation.

Overseas Special Session

Domestic Session